Home The Word Brain My Amedeo FAQ Privacy About Flying Publisher   


Oliena Studio

Stroke and language recovery: 9000+ videos

EspañolItalianoSarduEnglish | PDF+


  Liver Cirrhosis

  Free Subscription


23.09.2019

2 Dig Dis Sci
2 Hepatology
6 J Hepatol
2 PLoS One


  Retrieve available abstracts of this week’s articles:
HTML format
Text format
 
 
Single Articles


    Dig Dis Sci

  1. KOOLA JD, Ho SB, Cao A, Chen G, et al
    Predicting 30-Day Hospital Readmission Risk in a National Cohort of Patients with Cirrhosis.
    Dig Dis Sci. 2019 Sep 17. pii: 10.1007/s10620-019-05826.
    PubMed     Text format     Abstract available

  2. ALMANZA D, Gharaee-Kermani M, Zhilin-Roth A, Rodriguez-Nieves JA, et al
    Nonalcoholic Fatty Liver Disease Demonstrates a Pre-fibrotic and Premalignant Molecular Signature.
    Dig Dis Sci. 2019;64:1257-1269.
    PubMed     Text format     Abstract available


    Hepatology

  3. KUMAR A, Sharma P, Arora A
    Portal Pressure in Non-Cirrhotic Portal Hypertension: To Measure or Not to Measure.
    Hepatology. 2019 Sep 18. doi: 10.1002/hep.30957.
    PubMed     Text format     Abstract available

  4. DA BL, Koh C, Heller T
    REPLY: Portal Pressure in Non-Cirrhotic Portal Hypertension: To Measure or Not to Measure.
    Hepatology. 2019 Sep 18. doi: 10.1002/hep.30955.
    PubMed     Text format     Abstract available


    J Hepatol

  5. ROMANO A, Angeli P, Piovesan S, Noventa F, et al
    "Newly diagnosed Hepatocellular Carcinoma in patients with advanced hepatitis C treated with DAAs: a prospective population study".
    J Hepatol. 2018 Mar 15. pii: S0168-8278(18)30172.
    PubMed     Text format     Abstract available

  6. TURNER AM, Stolk J, Bals R, Lickliter J, et al
    Hepatic-targeted RNA interference provides persistent knockdown of alpha-1 antitrypsin levels in ZZ patients.
    J Hepatol. 2018 Mar 20. pii: S0168-8278(18)30176.
    PubMed     Text format     Abstract available

  7. TSUCHIDA T, Lee YA, Fujiwara N, Ybanez M, et al
    A Simple Diet- and Chemical-Induced Murine NASH Model with Rapid Progression of Steatohepatitis, Fibrosis and Liver Cancer.
    J Hepatol. 2018 Mar 20. pii: S0168-8278(18)30175.
    PubMed     Text format     Abstract available

  8. FORNS X, Sarrazin C
    Treatment of chronic hepatitis C.
    J Hepatol. 2018 Jun 8. pii: S0168-8278(18)32019.
    PubMed     Text format    

  9. RASSI AB, d'Amico EA, Tripodi A, Rocha TRFD, et al
    Fresh frozen plasma transfusion in patients with cirrhosis and coagulopathy: effect on conventional coagulation tests and thrombomodulin-modified thrombin generation.
    J Hepatol. 2019 Sep 16. pii: S0168-8278(19)30544.
    PubMed     Text format     Abstract available

  10. VITALE A, Majno-Hurst P
    Towards a personalized approach to hepatic resection in cirrhotic patients.
    J Hepatol. 2019 Sep 16. pii: S0168-8278(19)30541.
    PubMed     Text format    


    PLoS One

  11. NAVARRO VJ, Belle SH, D'Amato M, Adfhal N, et al
    Silymarin in non-cirrhotics with non-alcoholic steatohepatitis: A randomized, double-blind, placebo controlled trial.
    PLoS One. 2019;14:e0221683.
    PubMed     Text format     Abstract available

  12. SENKERIKOVA R, Frankova S, Jirsa M, Kreidlova M, et al
    PNPLA3 rs738409 G allele carriers with genotype 1b HCV cirrhosis have lower viral load but develop liver failure at younger age.
    PLoS One. 2019;14:e0222609.
    PubMed     Text format     Abstract available


Thank you for your interest in scientific medicine.


AMEDEO Liver Cirrhosis is free of charge.
This policy is made possible thanks to a media sponsorship by Boehringer Ingelheim.

Design: